Skip to content
OpenCapital
Get started

NuSkin Enterprises NUS Adjustments To Additional Paid In Capital Purchase Of Noncontrolling Interest

Other financials

Income statement

See full
Revenue$320.6M-12.0%
Gross profit$214.5M-13.2%
Operating income$4.0M+141%
Net income$1.8M-98.3%
EPS (diluted)$0.04-98.1%

Balance sheet

See full
Cash & equivalents$198.7M-2.5%
Total debt$303.6M-8.2%
Total equity$794.1M+5.3%
Total assets$1.4B-1.1%

Cash flow

See full
Operating cash flow-$3.9M-1,107%
CapEx$13.7M+1.0%
Free cash flow-$17.6M-33.6%

Valuation

See full
Market cap$256.35M-38.2%

Where this comes from

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept nus:AdjustmentsToAdditionalPaidInCapitalPurchaseOfNoncontrollingInterest.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is NuSkin Enterprises's adjustments to additional paid in capital purchase of noncontrolling interest?
NuSkin Enterprises (NUS) reported adjustments to additional paid in capital purchase of noncontrolling interest of $2.37M in Q1 2026.